Recombinant Human Anti-C12H18N4O7 Soluble TCR (ZIP-Fos/ZIP-Jun) (VS-0622-YF1468) (CAT#: VS-0622-YF1468)
Human TCR recognizes C12H18N4O7 peptide (5-(2-oxopropylideneamino)-6-D-ribitylaminouracil) in the context of human MR1. Soluble TCR expressed with ZIP-Fos/ZIP-Jun strategy (TRAV-TRAC partial-ZIP-Fos, TRBV-TRBC partial-ZIP-Jun) was validated to be able to bind pMHC in published references. The same expression strategy (ZIP-Fos/ZIP-Jun) is used to express this recombinant Human soluble TCR. Please note that the activity is not guaranteed.
Specifications
- Host Species
- Human
- Target
- C12H18N4O7
- Epitope
- 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil
- MHC
- human MR1
- Type
- Soluble TCR (ZIP-Fos/ZIP-Jun)
- TCR Expression Strategy
- ZIP-Fos/ZIP-Jun strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on ZIP-Fox/ZIP-Jun. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- 5-OP-RU; 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF1468. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: ELISA, SPR, Inhib, FuncS
Application: ELISA, FC
Application: WB, IHC, ELISA, FC
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, FC
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.